Advanced search
Publication Cover
Future Science OA Volume 10, 2024 - Issue 1
Submit an article Journal homepage
347
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Statin use is not associated with inflammation among Chilean women of Mapuche and non-Mapuche ancestry with gallstones

Sarah S Jackson1 Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6986-8842
ORCID Icon,
Marina Lex2 Department of Mathematics, The Technical University of Munich, Munich, Germany
,
Vanessa Van De Wyngard3 School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile;4 Advanced Center for Chronic Diseases (ACCDiS), FONDAP, Santiago, Chile
,
Paz Cook3 School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile;4 Advanced Center for Chronic Diseases (ACCDiS), FONDAP, Santiago, Chile
,
Allan Hildesheim1 Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD, USA
,
Ligia A Pinto5 Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA
,
Sharon H Jackson6 Division of Intramural Research, National Institute on Minority Health & Health Disparities, Bethesda, MD, USA
,
Kelvin Choi6 Division of Intramural Research, National Institute on Minority Health & Health Disparities, Bethesda, MD, USA
,
Tsion Zewdu Minas7 Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
,
Héctor Fabio Losada Morales8 Hepato-pancreatic & biliary surgery team, Surgery Department, Universidad de la Frontera, Temuco, Chile;9 Hepato-pancreatic & biliary surgery team, Hospital Dr. Hernán Henriquez Aravena, Temuco, Chile
,
Juan Carlos Araya4 Advanced Center for Chronic Diseases (ACCDiS), FONDAP, Santiago, Chile;10 Laboratorio de Inmunopatología Traslacional, Facultad de Ciencias, Universidad Mayor, Chile;11 Department of Pathology, Faculty of Medicine, Universidad de la Frontera, Temuco, Chile;12 Center for Cancer Prevention and Control, CECAN (ANID 152220002), Santiago, Chile
,
Catterina Ferreccio3 School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile;4 Advanced Center for Chronic Diseases (ACCDiS), FONDAP, Santiago, Chile
,
Jill Koshiol1 Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD, USA
&
Ruth M Pfeiffer1 Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD, USA
 show all
Article: 2340327 | Received 24 Feb 2023, Accepted 18 Oct 2023, Published online: 11 Jan 2024

References

  • Bertran E, Heise K, Andia ME, Ferreccio C. Gallbladder cancer: incidence and survival in a high-risk area of Chile. Int. J. Cancer 127(10), 2446–2454 (2010).
  • .Ferlay J, et al .Cancer statistics for the year 2020: An overview. Int. J. Cancer 149, 778–789 (2021).
  • Lorenzo Bermejo J, Boekstegers F, Gonzalez Silos R et al. Subtypes of Native American ancestry and leading causes of death: mapuche ancestry-specific associations with gallbladder cancer risk in Chile. PLoS Genet. 13(5), e1006756 (2017).
  • Espinoza JA, Bizama C, Garcia P et al. The inflammatory inception of gallbladder cancer. Biochim. Biophys. Acta 1865(2), 245–254 (2016).
  • Andreotti G, Chen J, Gao YT et al. Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China. Int. J. Cancer 122(10), 2322–2329 (2008).
  • Jackson SS, Van Dyke AL, Zhu B et al. Anthropometric Risk Factors for Cancers of the Biliary Tract in the Biliary Tract Cancers Pooling Project. Cancer Res. 79(15), 3973–3982 (2019).
  • Jackson SS, Van De Wyngard V, Pfeiffer RM et al. Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer. Scientific Reports. 11(1), 3686 (2021).
  • Koshiol J, Castro F, Kemp TJ et al. Association of inflammatory and other immune markers with gallbladder cancer: results from two independent case-control studies. Cytokine. 83, 217–225 (2016).
  • Liu Z, Kemp TJ, Gao YT et al. Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer. Sci Rep. 8(1), 5671 (2018).
  • Montecucco F, Burger F, Pelli G et al. Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. Rheumatology. 48(3), 233–242 (2009).
  • Schonbeck U, Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 109(21 Suppl. 1), II18–26 (2004).
  • Erichsen R, Frøslev T, Lash TL, Pedersen L, Sørensen HT. Long-term statin use and the risk of gallstone disease: a population-based case-control study. Am. J. Epidemiol. 173(2), 162–170 (2011).
  • Liu Z, Alsaggaf R, McGlynn KA et al. Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink. Gut 68(8), 1458–1464 (2019).
  • Koshiol J, Van De Wyngard V, McGee EE et al. The Chile Biliary Longitudinal Study: A Gallstone Cohort. Am. J. Epidemiol. 190(2), 196–206 (2021).
  • Yu K, Li Q, Bergen AW et al. Pathway analysis by adaptive combination of P-values. Genet. Epidemiol. 33(8), 700–709 (2009).
  • Abedin MZ, Narins SC, Park EH, Smith PR, Kirkwood KS. Lovastatin alters biliary lipid composition and dissolves gallstones: a long-term study in prairie dogs. Dig. Dis. Sci. 47(10), 2192–2210 (2002).
  • Bodmer M, Brauchli YB, Krahenbuhl S, Jick SS, Meier CR. Statin use and risk of gallstone disease followed by cholecystectomy. JAMA 302(18), 2001–2007 (2009).
  • Zdanowicz K, Bobrus-Chcociej A, Pogodzinska K et al. Analysis of Sphingolipids in Pediatric Patients with Cholelithiasis—A Preliminary Study. Journal of Clinical Medicine. 11(19), 5613 (2022).
  • Jackson SS, Lex M, Van De Wyngard V et al. Associations between statin use and inflammatory markers among Chilean women of Mapuche and non-Mapuche ancestry with gallstones. Scientific Reports 11(1), 3686 (2022).
  • Koshiol J, Gao YT, Corbel A et al. Circulating inflammatory proteins and gallbladder cancer: potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions. Cancer Epidemiol. 54, 25–30 (2018).
  • Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286(1), 64–70 (2001).
  • Rezaie-Majd A, Maca T, Bucek RA et al. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler. Thromb. Vasc. Biol. 22(7), 1194–1199 (2002).
  • Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des. 18(11), 1519–1530 (2012).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.